medigraphic.com
ISSN 1561-2929 (Print)

2016, Number 1

<< Back Next >>

RCAN 2016; 26 (1)

Influence of nutritional status upon functional capacity of chronic kidney patient subjected to home peritoneal dialysis

Álvarez GY, Bohorques RR, Rodas PA, Noa FL

Language: Spanish
References: 72
Page: 21-36
PDF size: 495.01 Kb.


ABSTRACT

Rationale: Peritoneal dialysis (PP) administered at home might be associated with preserved values of the nutritional status of the insufficient End-Stage-Kidney-Disease (ESKD) patient, and a better functional capacity. Objective: To identify the associations between nutritional status of ESKD patient subjected to home PD and functional capacity. Study design: Analytical, cross-sectional. Study serie: Thirtyseven insufficient ESKD-patients (Males: 54.1%; Ages ≥ 60 años: 18.9%; Blood hypertension: 40.5%; Diabetes mellitus: 24.3%) subjected to home PD (≥ 1 year admitted in the PD program: 54.0%) at the “Dr. Abelardo Buch López” Institute of Nephrology (La Habana, Cuba) between August 2014 and November 2014. Material and method: ESKD-patient’s functional capacity was measured with the Karnofsky scoring. Presence of inflammatory states was established by means of the measurement of the C-Reactive Protein (CRP). Nutritional status was determined after using the Subjective Global Assessment as modified by Kalantar-Zadeh et al. (1999). In addition, the current state of selected biochemical indicators of nutritional status was assessed. Results: Functional capacity was preserved in 83.8% of the studied patients. Nutritional disorders were present in 56.8% of them. Current state of biochemical variables was as follows: Hemoglobin ‹ 100.0 g.L-1: 18.9%; serum Albumin ‹ 35.0 g.L-1: 27.0%; and serum Total Cholesterol ‹ 3.8 mmol.L-1: 5.4%; respectively. Fifty-six point seven percent of the study serie presented with CPR values ≥ 6 mg.L-1. Patient’s functional capacity was independent from nutritional status, and the current values of determined biochemical indicators. Conclusions: ESKD-patients subjected to home DP distinguished themselves for their preserved functional capacity in spite of the found rate of nutritional disorders.


REFERENCES

  1. Kopple JD, Massry SG. Kopple and Massry's Nutritional management of renal disease. Lippincott Williams & Wilkins. New York: 2004.

  2. Barril Cuadrado G, Cebollada Muro J, Cerezo Morales S, Coronel Díaz F, Doñate Cubells T, Fernández Giraldez E; et al. Nutrición en pacientes en diálisis. Consenso SEDYT Sociedad Española de Diálisis y Trasplante. Diálisis y Trasplante [España] 2006;27:138-61.

  3. Pasticci F, Fantuzzi AL, Pegoraro M, McCann M, Bedogni G. Nutritional management of stage 5 chronic kidney disease. J Ren Care 2012; 38:8-16.

  4. Stenvinkel P, Carrero JJ, Axelsson J, Lindholm B, Heimbürger O, Massy Z. Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: How do new pieces fit into the uremic puzzle? Clin J Am Soc Nephrol 2008;3:505-21.

  5. Muntner P, Hamm LL, Kusek JW, Chen J, Whelton PK, He J. The prevalence of non-traditional risk factors for coronary heart disease in patients with chronic kidney disease. Ann Intern Med 2004; 140:9-17.

  6. Beddhu S, Pappas LM, Ramkumar N, Samore M. Effects of body size and body composition on survival in hemodialysis patients. J Am Soc Nephrol 2003;14: 2366-2372.

  7. Salahudeen AK. Obesity and survival on dialysis. Am J Kidney Diseases 2003; 41:925-32.

  8. Gore JL, Pham PT, Danovitch GM, Wilkinson AH, Rosenthal JT, Lipshutz GS, Singer JS. Obesity and outcome following renal transplantation. Am J Transplant 2006;6:357-63.

  9. Johnson DW, Isbel NM, Brown AM, Kay TD, Franzen K, Hawley CM; et al. The effect of obesity on renal transplant outcomes. Transplantation 2002;74: 675-81.

  10. Dukkipati R, Kopple JD. Causes and prevention of protein-energy wasting in chronic kidney failure. Semin Nephrol 2009;29:39-49.

  11. Kovesdy CP, Kalantar-Zadeh K. Why is protein-energy wasting associated with mortality in chronic kidney disease? Semin Nephrol 2009;29:3-14.

  12. Bonanni A, Mannucci I, Verzola D, Sofia A, Saffioti S, Gianetta E; et al. Protein-energy wasting and mortality in chronic kidney disease. Int J Environ Res Public Health 2011;8:1631-54.

  13. Marcen R, Gámez C, de la Cal MA; para el Grupo de Estudio Cooperativo de Nutrición en Hemodiálisis. Estudio Cooperativo de Nutrición en Hemodiálisis II: Prevalencia de malnutrición proteico-calórica en los enfermos en hemodiálisis. Nefrología [España] 1994;14(Supl 2):S36-S43.

  14. Marcen R, Teruel JL, De la Cal MA, Gámez C. The impact of malnutrition in morbidity and mortality in stable haemodialysis patients. Spanish Cooperative Study of Nutrition in Hemodialysis. Nephrol Dial Transplant 1997;12:2324-31.

  15. Farrell PC, Hone PW. Dialysis-induced catabolism. Am J Clin Nutr 1980;33: 1417-22.

  16. Ikizler TA, Wingard RL, Sun M, Harvell J, Parker RA, Hakim RM. Increased energy expenditure in haemodialysis patients. J Am Soc Nephrol 1996; 7:2646-53.

  17. Stevenson FT. Inflamation and end-stage renal disease: Recent insights. Semin Dial 1998;11:119-23.

  18. Puchulu MB, Inflamación y nutrición en la enfermedad renal crónica. DIAETA [Buenos Aires: Argentina] 2011;29: 16-22.

  19. Kalantar-Zadeh K, Ikizler A, Block G, Avram MM, Kopple JD. Malnutrition- Inflammation Complex Syndrome in dialysis patients: Causes and Consequences. Am J Kidney Dis 2003; 42:864-81.

  20. Gracia Iguacel C, González Parra E, Barril Cuadrado G, Sánchez R, Egido J, Ortiz Arduán J, Carrero J. Definiendo el síndrome de desgaste proteico energético en la enfermedad renal crónica: Prevalencia e implicaciones clínicas. Nefrología 2014;34:507-19.

  21. Blumenkrantz MJ, Gahl GM, Kopple JD, Kamdar AV, Jones MR, Kessel M, Coburn JW. Protein losses during peritoneal dialysis. Kidney Intern 1981; 19:593-602.

  22. Stenvinkel P, Chung SH, Heimburger O, Lindholm B. Malnutrition, inflammation, and atherosclerosis in peritoneal dialysis patients. Perit Dial Int 2001;21(Suppl): S157-S162.

  23. Jiménez S, Muelas F, Segura P, Borrego F, Gil J, Liébana A. Evaluación global subjetiva y escala de malnutricióninflamación para valorar el estado nutricional de pacientes en diálisis peritoneal con hipoalbuminemia. Enferm Nefrol [España] 2012;15:87-93.

  24. Sánchez S, Fernández Reyes MJ, Celadilla O, Martínez MV, Muñoz I, Rodrigo N; et al. Nutrición en pacientes de diálisis peritoneal. Un reto para enfermería. Estudio transversal. Enferm Nefrol 1996;4:278-84. Disponible en: http://www.revistaseden.org/files/Nutrici on_en_pacientes_de_dialisis_peritoneal. pdf. Fecha de última visita: 12 de Enero del 2016.

  25. Dombros NV, Digenis GE, Oreopoulos DG. Is malnutrition a problem for the patient on peritoneal dialysis? Perit Dial Int 1995;15(Suppl 5):S10-S19.

  26. Chung SH, Lindholm B, Lee HB. Is malnutrition an independent predictor of mortality in peritoneal dialysis patients? Nephrol Dial Transplant 2003;18: 2134-40.

  27. Abbott KC, Glanton CW, Trespalacios FC, Oliver DK, Ortiz MI, Agodoa LY; et al. Body mass index, dialysis modality, and survival: Analysis of the United States Renal Data System Dialysis Morbidity and Mortality Wave II study. Kidney Int 2004;65:597-605.

  28. Lu Q, Cheng LT, Wang T, Wan J, Liao LL, Zeng J; et al. Visceral fat, arterial stiffness, and endothelial function in peritoneal dialysis patients. J Renal Nutr 2008;18:495-502.

  29. Guerrero Risco A. Nutrición y diálisis adecuada en diálisis peritoneal. Enfermería Nefrológica [Sevilla: España] 1998;5:6-17. Disponible en: http://www.revistaseden.org/files/rev36_ 1.pdf#page=3. Fecha de última visita: 15 de Febrero del 2016.

  30. Diez JJ, Iglesias P, Selgas R. Diabetes, hiperlipemia y obesidad en una unidad de diálisis peritoneal: Estudio descriptivo transversal. Nefrología [España] 1995; 15:156-62.

  31. Bohorques Rodríguez R, Álvarez González Y, Vázquez Adán Y, Martínez Torres A, Santana Porbén S. Estado nutricional de los nefrópatas sujetos a diálisis ambulatoria en unidades de 4 provincias de Cuba. RCAN Rev Cubana Aliment Nutr 2013;23:97-112.

  32. Snyder JJ, Foley RN, Gilbertson DT, Vonesh EF, Collins AJ. Body size and outcomes on peritoneal dialysis in the United States. Kidney Int 2003;64: 1838-44.

  33. Pérez-Oliva Díaz J. Estado de las terapias de sustitución de la función renal en Cuba. RCAN Rev Cubana Aliment Nutr 2014;24(2 Supl):S18-S25.

  34. Pérez-Oliva Díaz J, Pérez Campa R, Herrera Valdés R, Almaguer M, Brisquet E. Terapia renal de reemplazo dialítica en Cuba: Tendencia durante los últimos 10 años. Rev Haban Cienc Méd [Cuba] 2012;11:424-33. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_ arttext&pid=S1729- 519X2012000300014&lng=es. Fecha de última visita: 12 de Enero del 2016.

  35. Montenegro J, Olivares J, Ocharan- Corcuera J. La diálisis peritoneal. Gaceta Médica Bilbao 2000;97:93-9.

  36. Popovich RP, Moncrief JW, Nolph KD, Ghods AJ, Twardowski ZJ, Pyle WK. Continuous ambulatory peritoneal dialysis. Ann Int Med 1978;88:449-56.

  37. Oreopoulos DG, Robson M, Izatt S, Clayton S, De Veber GA. A simple and safe technique for continuous ambulatory peritoneal dialysis (CAPD). ASAIO Journal 1978;24:484-9.

  38. Ronco C, Diaz-Buxo JA. Automated peritoneal dialysis. Nephron 2001;87: 1-7.

  39. Kalantar-Zadeh K, Kleiner M, Dunne E, Lee GH, Luft FC. A modified quantitative subjective global assessment of nutrition for dialysis patients. Nephrol Dial Transplant 1999;14:1732-8.38.

  40. Weiner JS, Lourie JA. Human biology.A guide to field method. International Biological Program. Handbook number 9. Blackwell Scientific Publications Ltd. Oxford: 1969.

  41. Lohman TG, Roche AF, Martorell R. Anthropometric standardization reference manual. Second Edition. Human Kinetics Books. Champaign, Illinois: 1991. Pp 44-7.

  42. Shetty PS, James WPT. Body mass index: A measure of chronic energy deficiency in adults. FAO Food and Nutrition Paper number 56. Rome: 1994. Pp 10-11.

  43. Karnorfsky DA, Abelman WH, Craver LF, Burchenal JH. The use of nitrogen mustards in the palliative treatment of cancer. Cancer 1948;1:634-645.

  44. Karnofsky DA, Burchenal JH. The clinical evaluation of chemotherapeutic agents in cancer. En: Evaluation of chemotherapeutic agents [Editor: MacLeod CM]. Columbia University Press. New York: 1949. pp 191-205.

  45. Dalas Guiber M, Fernández Uriarte Y, Castelo Villalón X, Sanz Guzmán DM. Estado nutricional y capacidad funcional del nefrópata terminal en hemodiálisis crónica. RCAN Rev Cubana Aliment Nutr 2010;20:192-212.

  46. Santana Porbén S, Martínez Canalejo H. Manual de Procedimientos Bioestadísticos. Segunda Edición. EAE Editorial Académica Española. ISBN-13: 9783659059629. ISBN-10: 3659059625. Madrid: 2012.

  47. Santana Porbén S. Estado de la desnutrición asociada a la enfermedad renal crónica. RCAN Rev Cubana Aliment Nutr 2014;24(2 Supl 1): S62-S66.

  48. Bohorquez Rodríguez R, Barranco Hernández E, Martínez Díaz AM. Valoración nutricional de pacientes con insuficiencia renal crónica terminal al iniciar terapéutica dialítica. Rev Cubana Med 1985;24:871-6. Reimpreso en: RCAN Rev Cubana Aliment Nutr 2013;23:173-8.

  49. de Luis Román D, Bustamante J. Aspectos nutricionales en la insuficiencia renal. Nefrología [España] 2008;28: 333-42.

  50. Miyamoto T, Carrero JJ, StenvinkelP. Inflammation as a risk factor and target for therapy in chronic kidney disease. Curr Opin Nephrol Hypertens 2011;20: 662-8.

  51. Carrero JJ, Stenvinkel P. Inflammation in end-stage renal disease- What have we learned in 10 years? Semin Dial 2010;23: 498-509.

  52. Ikizler TA. Nutrition, inflammation and chronic kidney disease. Curr Op Nephrology Hypertension 2008;17: 162-7.

  53. Kalantar-Zadeh K, Kopple JD. Relative contributions of nutrition and inflammation to clinical outcome in dialysis patients. Am J Kidney Dis 2001; 38:1343-50.

  54. Cano NJ, Heng AE, Pison C. Multimodal approach to malnutrition in malnourished maintenance hemodialysis patients. J Ren Nutr 2011;21:23-6.

  55. Schreiber MJ. Can malnutrition be prevented? Perit Dial Int 1995;15(Suppl 5):S39-S49.

  56. Pifer TB, McCullough KP, Port FK, Goodkin DA, Maroni BJ, Held PJ, Young EW. Mortality risk in hemodialysis patients and changes in nutritional indicators: DOPPS. Kidney Int 2002;62:2238-45.

  57. Durán AM, Piñón JGF. Mortalidad en ingresos a diálisis peritoneal. Estudio comparativo de la modalidad continua ambulatoria y automatizada. Rev Fac Med UNAM 2009;52(5):0-0. Disponible en: http://www.medigraphic.com/pdfs/facme d/un-2009/un095b.pdf. Fecha de última visita: 15 de Febrero del 2016.

  58. Blummenkrantz MZ, Kopple JD, Moran JK, Coburn JW. Metabolic balance studies and dietary protein requirements in patiens in CAPD. Kidney Int 2013; 21:849-61.

  59. Kalantar-Zadeh K, Abbott KC, Salahudeen AK, Kilpatrick RD, Horwich TB. Survival advantages of obesity in dialysis patients. Am J Clin Nutr 2005; 81:543-54.

  60. Salahudeen AK. Obesity and survival on dialysis. Am J Kidney Dis 2003;41: 925-932.

  61. Palomares Bayo M, Quesada Granados JJ, Osuna Ortega A, Asensio Peinado C, Oliveras López MJ, López G de la Serrana H; et al. Longitudinal study on the body mass index (BMI) of dialysis patients. Nutrición Hospitalaria [España] 2006;21:155-62.

  62. Churchill DN, Thorpe K, Taylor DW, KeshaviahP, for the Canadá-USA Study of Peritoneal Dialysis Adequancy. Adequancy of dialysis and nutrition in continuous peritoneal dialysis: Association with clinical outcomes. J Am Soc Nephrol 1996;7:198-207.

  63. Tzamaloukas AH. Risk of extracellular volume expansion in long-term peritoneal dialysis. Adv Perit Dial 2005;21:106-11.

  64. Boulanger E. Peritoneal and systemic inflammation: The benefits of using biocompatible peritoneal dialysis fluids. Perit Dial Int 2008;28:28-31.

  65. Álvarez González Y, Bohorques Rodríguez R, Martínez Torres A, Ballard Álvarez Y, Pérez Canepa S, Gutiérrez García F. Peritonitis en un programa de diálisis peritoneal domiciliaria en el Instituto de Nefrología, 2007-2011. Rev Cubana Medicina 2012;51:117-23.

  66. De Sousa E, Auxiliadora M, Del Peso G, Castro MJ, Celadilla O, Selgas Gutierrez R. Experiencia de 30 años en una unidad de diálisis peritoneal. Supervivencia a largo plazo. Nefrología 2013;33:546-51.

  67. Hemke AC, Dekker FW, Bos WJ, Krediet RT, Heemskerk MB, Hoitsma AJ. Causes of decreased use of peritoneal dialysis as a kidney replacement therapy in the Netherlands. Ned Tijdschr Geneeskd 2012;156:38-71.

  68. Thong MS, van Dijk S, Noordzij M, Boeschoten EW, Krediet RT, Dekker FW, Kaptein AA; Netherlands Cooperative Study on the Adequacy Study Group. Symptom clusters in incident dialysis patients: Associations with clinical variables and quality of life. Nephrol Dial Transplant 2009;24: 225-30.

  69. Heimburger O, Waniewski J, Werynski A, Lindholm B. A quantitative description of solute and fluid transport during peritoneal dialysis. Kidney Int 1992;41:1320-32.

  70. Burkart JM. Effect of peritoneal dialysis prescription and peritoneal membrane transport characteristics on nutritional status. Perit Dial Int 1995;15(Suppl 5): S20-S35.

  71. Tsimihodimos V, Dounousi E, Siamopoulos K. Dislypemia in chronic kidney disease: A approach to pathogenesis and treatment. Am J Nephrol 2008;28:958-73.

  72. Tse KC, Lam MF, Yip PS, et al. A longterm study on hyperlipidemia in stable renal transplant recipients. Clin Transplant 2004;18:274-80.




2020     |     www.medigraphic.com